Cardiology Fellow @MonteHeart | @EinsteinMed | @UChicago Biochem | Interested in humans, computers, and what they know about each other
Joined January 2021
- Tweets 212
- Following 1,129
- Followers 175
- Likes 569
14 Photos and videos
David Flomenbaum, MD, MS retweeted
6 Dec 2025
Welcome to the MonteHeart family! We are thrilled to introduce our new cardiology fellows and excited for all the learning, collaboration, and innovation ahead
@AdityaDewanjee_ @SakthisuryaP @NathalieRosasMD
@AlexandrinaDan @Aneel_Maini @gal_rubinstein
@MatteoSturlaM @panos_zb
2
16
117
28,575
David Flomenbaum, MD, MS retweeted
2 Jul 2025
Excited to welcome an incredible new group of Montefiore cardiology fellows!!
@MonteHeart @MontefioreNYC @EinsteinMed @aschenonegiugni
@SanyaChhikara @kaurarpanjeetMD @Swagata_P @SpringMD @bhalla_js @SaraswatiUshasi @DFlomenbaum @KayvonGhoreshi @BrownDonclair @JustinSongMD
4
40
4,799
7 Dec 2024
🥰🥰🥰
6 Dec 2024
We are beyond excited to welcome this stellar new class of cardiology fellows! 💫🫀🎉 Congratulations and welcome to MonteHeart! #cardiology #montefiore #monteheart #matchday @aschenonegiugni @GGreenbergMD @CardioMDPhD @barillas_irene @CrisZamoraMD @ZhanglilyA
11
779
David Flomenbaum, MD, MS retweeted
15 Nov 2024
Interested in using LLMs to automate writing clinical notes?
Remember stories like this, which happen all the time.
Writing = thinking. LLMs can and do help us think, but not if they are implemented thoughtlessly.
Sent a patient home last week without evaluating a concern. Decided it didn't warrant evaluation.
An hour later, while typing note, I had second thoughts. Called the pt and scheduled a test. Got the results today. Very glad I did the test. A close call.
5
16
126
19,124
David Flomenbaum, MD, MS retweeted
7 Nov 2024
🧵regarding the introducer sheath commonly known as a 'Cordis' catheter.
We'll go over what it was originally designed for and why it ended up being adopted by other specialties for entirely different reasons.
Also we'll look at its accessories and see what's inside one.
(1/ )
15
176
771
207,462
David Flomenbaum, MD, MS retweeted
8 Oct 2024
"Is there a doctor on the plane?"✈️🩺
Responding to in-flight medical emergencies.
#MedTwitter
46
1,685
6,899
842,758
David Flomenbaum, MD, MS retweeted
24 Sep 2024
The "yo-yo diet" that alternates high and low fat markedly accelerates atherosclerosis compared with a continuous high fat diet
nature.com/articles/d41586-0… @NatureNV @justsaysinmice
Two independent studies in mice highlight the profound impact of diet on the innate immune response
@danrader333 @ktc_phd
4
107
338
59,456
David Flomenbaum, MD, MS retweeted
4 more performances to see @MontefioreIm's very own Dr. Sarah Tupchong in @lifelinemusical off-Broadway @signatureinnyc. Kudos to Sarah for contributing her onstage talents while shining as a 2nd-year resident!
ALT Dr. Sarah Tupchong, bottom row, 2nd from left, with fellow chorus members of Lifeline the Musical outside the Signature Theater off-Broadway.
2
1
1,792
8 Jun 2024
Cool! AUROC of 0.95 for detection of HF compared against at-risk controls using a smartphone alone
jacc.org/doi/full/10.1016/j.…
1
162
19 Apr 2024
“The ECG is just a test: a Bayesian approach to acute coronary occlusion”
2
290
David Flomenbaum, MD, MS retweeted
11 Apr 2024
Things We Do for No Reason™: Routine respiratory pathogen panels for emergency department and hospitalized patients shmpublications.onlinelibrar…
3
16
51
9,252
David Flomenbaum, MD, MS retweeted
14 Mar 2024
In this @JACCJournals #JACCAdvances editorial, @RBPatelMD and I discuss the clinical and subclinical risk factors a/w cryptogenic stroke.
Given the relationship between AF and stroke, impt to appropriately adjudicate AF clinically, and in future studies
authors.elsevier.com/sd/arti…
2
6
27
1,815
David Flomenbaum, MD, MS retweeted
8 Apr 2024
🚀🫀Explore recent breakthroughs, future directions, and evaluation & infrastructure needs for #AI-augmented cardiovascular care. Learn more in our two-part review published in @JACCJournals #ACC24.
Part 1: jacc.org/doi/10.1016/j.jacc.…
Part 2: jacc.org/doi/10.1016/j.jacc.…
3
16
56
14,127
EPIC-SR trial: In fully vaccinated patients with risk factors for severe disease and patients (vaccinated or unvaccinated) without such risk factors, nirmatrelvir–ritonavir did not significantly shorten the time to alleviation of Covid-19 symptoms. nej.md/49kLhq3
ALT Table 2. Time to Sustained Alleviation of All Targeted Signs and Symptoms through Day 28.
10
103
201
471,237
4 Apr 2024
RT @EricTopol: Some exciting new GLP-1 drug randomized trial evidence for *potential* disease-modifying impact on #Parkinsons disease (ther…
188
4 Apr 2024
‼️‼️‼️
3
154
David Flomenbaum, MD, MS retweeted
1 Apr 2024
The information embedded in medical scans is far beyond what we've considered. Recently, deep learning of chest X-rays provided better insight for risk of heart attack and stroke than our traditional risk score.
Reviewed in the new Ground Truths (link in profile)
8
113
469
61,103